Covered recipient · General Payments record
REUEL M GREGORY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$1,431.50
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.81 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $134.71 | 7 |
| Acerta Pharma LLC | $60.40 | 4 |
| Novo Nordisk AS | $51.75 | 3 |
| DEXCOM, INC. | $50.49 | 2 |
| PFIZER INC. | $44.97 | 3 |
| QOL Medical, LLC | $30.38 | 1 |
| Sumitomo Pharma America, Inc. | $21.10 | 1 |
| Amgen Inc. | $18.16 | 1 |
| Merck Sharp & Dohme Corporation | $13.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20202021
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.16 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117567640 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.30 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104653309 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.64 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104672093 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.87 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105676231 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.59 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105224612 | CMS |
| Dexcom, Inc. | $28.27 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153330443 | CMS |
| Dexcom, Inc. | $22.22 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153330445 | CMS |
| Lilly USA, LLC | $28.06 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135384243 | CMS |
| Lilly USA, LLC | $19.79 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135384245 | CMS |
| Lilly USA, LLC | $14.87 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135364443 | CMS |
| Lilly USA, LLC | $19.31 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135356465 | CMS |
| Lilly USA, LLC | $20.85 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135384939 | CMS |
| Lilly USA, LLC | $23.62 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135363151 | CMS |
| Lilly USA, LLC | $8.21 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135363149 | CMS |
| Merck Sharp & Dohme LLC | $13.85 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141980457 | CMS |
| Novo Nordisk Inc | $16.95 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097254121 | CMS |
| Novo Nordisk Inc | $19.55 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097672244 | CMS |
| Novo Nordisk Inc | $15.25 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096876031 | CMS |
| PFIZER INC. | $17.71 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131725254 | CMS |
| PFIZER INC. | $13.98 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132083440 | CMS |
| PFIZER INC. | $13.28 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131093215 | CMS |
| QOL Medical, LLC | $30.38 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147729328 | CMS |
| Sumitomo Pharma America, Inc. | $21.10 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148858845 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2024
- Source files
- Dataset page · Bulk file · PY2020 , PY2021 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.